Real-time cell viability monitoring for high-throughput drug screening using tumor xenograft-derived cells.
- DOI
- 10.1016/j.crmeth.2026.101464
- Published
- 2026 Jul 20
- Container
- Cell reports methods
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.crmeth.2026.101464,
title = {Real-time cell viability monitoring for high-throughput drug screening using tumor xenograft-derived cells.},
author = {Esmaeilishirazifard E and Guerrero-Romero D and Lui AJW and Shea A and Nguyen LV and Callari M and Masina R and Tu K and Baird R and Edwards P and Greenwood W and Fuller S and Crafter C and Lawson M and Bruna A and Rueda OM and Caldas C},
year = {2026},
journal = {Cell reports methods},
doi = {10.1016/j.crmeth.2026.101464},
url = {https://doi.org/10.1016/j.crmeth.2026.101464}
}RIS
TY - JOUR TI - Real-time cell viability monitoring for high-throughput drug screening using tumor xenograft-derived cells. AU - Esmaeilishirazifard E AU - Guerrero-Romero D AU - Lui AJW AU - Shea A AU - Nguyen LV AU - Callari M AU - Masina R AU - Tu K AU - Baird R AU - Edwards P AU - Greenwood W AU - Fuller S AU - Crafter C AU - Lawson M AU - Bruna A AU - Rueda OM AU - Caldas C PY - 2026 JO - Cell reports methods DO - 10.1016/j.crmeth.2026.101464 UR - https://doi.org/10.1016/j.crmeth.2026.101464 ER -
APA
E, E., D, G., AJW, L., A, S., LV, N., M, C., R, M., K, T., R, B., P, E., W, G., S, F., C, C., M, L., A, B., OM, R., & C, C. (2026). Real-time cell viability monitoring for high-throughput drug screening using tumor xenograft-derived cells.. Cell reports methods. https://doi.org/10.1016/j.crmeth.2026.101464
Source records
- pubmed · retrieved 2026-09-26T10:33:49.894Z